News

Leon Herndon, MD, President of the American Glaucoma Society, sat down with David Hutton of Ophthalmology Times to discuss the AGS meeting held in Huntington Beach and what attendees can expect as well as new and exciting information to come from the meeting.

In an annual report, the company revealed the impact of a dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability.

According to the company, Stargardt disease is an orphan blindness disease that affects approximately 35,000 people in the United States.

Stargardt disease is an orphan blindness disease that affects approximately 35,000 people in the United States.

The algorithms could provide major accessibility improvements and cost savings to underdeveloped regions

Penetrating keratoplasty remains a popular choice for certain patients

According to the company, its proprietary non-viral gene therapy platform with minimally invasive delivery technology is providing long lasting gene expression and favorable distribution in the retina.

Bonnie An Henderson, MD, leads HelpMeSee to provide advanced cataract surgery training globally, emphasizing humanitarian aid and innovative simulation technology.

Several eye care products sold at Walmart and CVS locations have been recalled due to FDA findings during a facility inspection conducted earlier this month.

According to the company, 2,500 clinical and peer-reviewed studies that span 235 disease states have demonstrated the clinical utility of Optos technology.

The patch is the world's first non-degradable, synthetic tissue substitute for ophthalmic surgery.

The authors suggested genetic mutation may relax the body’s defences and allow harmful bacteria to reach the eye.

ECP105 has been developed for the recovery of post-surgical treatment of glaucoma.

The authors suggested genetic mutation may relax the body’s defences and allow harmful bacteria to reach the eye

The Retinopathy of Prematurity (ROP) Education and Support Programme is part of ROP Awareness Week, recognised from 26 February to 3 March

Prevent Blindness is offering a variety of free educational resources to the public and professionals

Researchers have found that the interactive release of anti-inflammatory drugs depend on the level of retinal degeneration. A customized treatment approach is expected to be developed to reduce patients’ inconvenience of having multiple shots.

Structural and vascular changes detected in RVO-affected eyes and unaffected fellow eyes

The treatment is a minimally invasive intravitreal injection that can be performed with a topical anesthetic.

A new initiative from Prevent Blindness will kick off to provide free educational resources on retinopathy of prematurity.

Increased levels of p-tau181 and p-tau127 and a decreasing cerebrospinal fluid Aβ42/40 ratio better defines progression from preclinical to manifest Alzheimer’s disease.

AI matched and outshone human specialists.

Annual meeting continues to offer key education opportunities.

Innovative therapies scale up to meet needs of a growing patient population